The Star Malaysia - StarBiz

Public Bank continues to command premium valuation

-

KUALA LUMPUR: RHB Research is maintainin­g its “buy” call on Public Bank Bhd, raising its target price from RM20.60 to RM21.60 after its results for January-september beat its own estimates and consensus.

The research house said Public Bank’s third quarter earnings had normalised on strong fee income and net interest margin (NIM) recovery.

“Management continued to strengthen asset quality, and took the opportunit­y to boost loan loss coverage (LLC) to a high 209%. Its share price has risen 21% on vaccine news, lifting FY21F price-to-book value (P/BV) to 1.4 times.

“We believe Public Bank will continue to command premium valuation, given its defensive qualities in the challengin­g economic environmen­t,” it said.

RHB Research said the bank’s net profit of Rm1.39bil (+39% q-o-q, +2% y-o-y) for the third quarter lifted 9M20 earnings to Rm3.72bil (-9% y-o-y). The nine months net profit accounted for 82% to 80% of its and consensus estimates.

It said Public Bank’s management does not expect a significan­t uptick in loans under the Targeted Repayment Assistance (TRA), with the enhanced TRA for B40 individual­s and micro enterprise­s. It also said credit cost guidance has been raised to 30bps-35bps (from 20bps-25bps), as management intends to take more pre-emptive provisions in fourth quarter to strengthen buffers.

“Loan growth is expected to exceed 4%, with deposits growing in tandem. NIM is expected to narrow by 20bps. We increase net profit by 4% and 3% for FY20F-21F.”

Newspapers in English

Newspapers from Malaysia